MedPath

NGX267

Generic Name
NGX267
Drug Type
Small Molecule
Chemical Formula
C10H18N2OS
CAS Number
503431-81-0
Unique Ingredient Identifier
8D3PZX7G73

Overview

NGX267 is a muscarinic agonist. It is developed for the treatment of Alzheimer’s disease and has shown the potential to both reduce symptoms and slow disease progression.

Background

NGX267 is a muscarinic agonist. It is developed for the treatment of Alzheimer’s disease and has shown the potential to both reduce symptoms and slow disease progression.

Indication

Investigated for use/treatment in alzheimer's disease and schizophrenia and schizoaffective disorders.

Associated Conditions

No associated conditions information available.

Clinical Trials

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath